Looking for volunteers
PEnile ReHABilitation After Nerve Sparing Robot-assisted Radical Prostatectomy for Prostate Cancer 2.0 (PEHAB-II)
NCT06875258 · The Netherlands Cancer Institute · Updated 13 March 2025
- What is being tested
- Sildenafil; Erectile vacuum device
- For
- Erectile Dysfunction Following Radical Prostatectomy
- Kind of study
- Tests a treatment or device on volunteers. Phase 4.
- Who can join
- Ages 18 years to 70 years. About 198 people. The full rules are on the registry page.
- Where
- Netherlands (3 sites)
- When
- Starts or started 15 Jan 2024, ends 1 Jan 2027. Registered 13 March 2025.
- Results
- None posted yet.
In the researchers' words
The PEHAB-II study is prospective, randomized trial designed to assess the effect of two different rehabilitation strategies on the recovery of erectile function in nerve sparing prostatectomy patients. The two rehabilitation strategies consist of 1)12 months daily doses of 100 mg Sildenafil combined with vacuum device (VED) therapy for 10 minutes a day, five times a week or 2) Standard of care: monotherapy with an on-demand dosage of 100mg Sildenafil. The study will be performed in multiple centers in the Netherlands.
Sites
- Canisius Wilhelmina ZiekenhuisNijmegen, Gelderland, Netherlands
- Antoni van Leeuwenhoek hospital, Netherlands Cancer InstituteAmsterdam, North Holland, Netherlands
- Maasstad ziekenhuisRotterdam, South Holland, Netherlands